Sacubitril valsartan has a highly selective inhibition of enkephalinase, blocks angiotensin receptors, and plays an important role in improving heart failure, reducing ejection fraction, and controlling blood pressure [15, 27, 28]. This evidence concerns the gene MME and heart failure.